Afpin Cl Caps
Zuventus Healthcare Ltd - capsule - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Zuvog 0.2 Tab.
You are viewing
Zuvog 0.2 Tab
tablet - 10 S
₹79
₹7.92 per tablet
Intas Pharmaceuticals Ltd · tablet - 0.2 mg - 10 S · Rx
₹54
₹5.44 per tablet
MANKIND (PHARMA) · tablet - 15 S · Rx
₹110
₹7.32 per tablet
Voglibose (0.2mg)
Management of type 2 diabetes mellitus; helps control post-meal (postprandial) blood glucose levels, usually as an add-on to diet/exercise and/or other antidiabetic medicines.
Voglibose is an alpha-glucosidase inhibitor that delays the breakdown and absorption of carbohydrates in the small intestine. This reduces the rise in blood sugar after meals and helps improve overall glycaemic control.
Oral tablet. Typically taken just before meals (or with the first bite of food) as prescribed by a doctor. Swallow with water; follow diet and exercise advice and monitor blood glucose regularly.
Common side effects of Zuvog 0.2 Tab may include:
Zuventus Healthcare Ltd - capsule - 10 S
Standard delivery

Zuventus Healthcare Ltd - 200 ml
Standard delivery
Zuventus Healthcare Ltd - 200 ml
Standard delivery

Zuventus Healthcare Ltd - tablet - 1 gm - 10 S
Standard delivery

Zuventus Healthcare Ltd - tablet - 10 S
Standard delivery

Zuventus Healthcare Ltd - tablet - 10 S
Standard delivery

Zuventus Healthcare Ltd - drop - 10 ml
Standard delivery

Zuventus Healthcare Ltd - 30 ml
Standard delivery
SYSTOPIC LAB · tablet - 10 Tablet · Rx
₹79
₹7.88 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Zuvog 0.2 Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Use under medical supervision in diabetes. Not recommended in type 1 diabetes or diabetic ketoacidosis. Use with caution in intestinal disorders (inflammatory bowel disease, colonic ulceration), intestinal obstruction/predisposition, or significant digestive disorders. Monitor liver function if advised; stop and seek care if severe abdominal symptoms occur. Hypoglycaemia risk increases when combined with insulin/sulfonylureas—carry glucose and treat lows with glucose (not sucrose).